Regulus Therapeutics Inc.

NASDAQ: RGLS · Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM

Regulus Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.92 -0.81 -0.74 -0.99
PEG Ratio
0.04 0.05 0.02 0.04
PS Ratio
n/a n/a n/a n/a
PB Ratio
1.17 1.15 0.63 0.50
P/FCF Ratio
-2.12 -0.89 -0.81 -1.12
P/OCF Ratio
-2.14 -0.91 -0.82 -1.14
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.00 0.11 0.19 0.13
Quick Ratio
10.98 2.96 3.78 12.48
Current Ratio
10.98 3.31 3.78 12.48
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-316.71 -51.5 -41.05 -32.53
Return on Equity
-0.61 -1.42 -0.85 -0.51
Return on Assets
-0.55 -0.98 -0.61 -0.41
Return on Invested Capital
-0.65 -1.32 -0.71 -0.44
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a